Health Care [ 9/12 ] | Health Care Equipment & Supplies [ 61/73 ]
NASDAQ | Common Stock
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.
Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system.
In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing.
The company is headquartered in Toronto, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 13, 25 | -11.23 Decreased by -568.70% | -14.62 Increased by +23.16% |
| Mar 31, 25 | -11.23 Decreased by -458.71% | -10.01 Decreased by -12.19% |
| Nov 13, 24 | -1.21 Increased by +26.34% | -1.20 Decreased by -0.67% |
| Aug 13, 24 | -3.05 Decreased by -125.93% | -1.43 Decreased by -113.29% |
| May 15, 24 | -1.68 Increased by +9.19% | -1.53 Decreased by -9.80% |
| Feb 13, 24 | -2.01 Decreased by -1.34 K% | -1.18 Decreased by -70.34% |
| Nov 14, 23 | -1.64 Decreased by -645.45% | -1.51 Decreased by -8.61% |
| Aug 14, 23 | -1.35 Decreased by -743.75% | -1.54 Increased by +12.34% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 13.64 M Decreased by -21.95% | -12.36 M Decreased by -26.23% | Decreased by -90.62% Decreased by -61.72% |
| Dec 31, 24 | 15.77 M Decreased by -13.05% | -7.96 M Increased by +28.35% | Decreased by -50.52% Increased by +17.59% |
| Sep 30, 24 | 15.01 M Decreased by -14.81% | -9.29 M Decreased by -2.40% | Decreased by -61.88% Decreased by -20.21% |
| Jun 30, 24 | 16.58 M Decreased by -17.40% | -19.95 M Decreased by -169.28% | Decreased by -120.32% Decreased by -226.00% |
| Mar 31, 24 | 17.48 M Decreased by -14.87% | -9.79 M Decreased by -1.78% | Decreased by -56.03% Decreased by -19.55% |
| Dec 31, 23 | 18.13 M Decreased by -25.34% | -11.12 M Decreased by -11.83% | Decreased by -61.31% Decreased by -49.79% |
| Sep 30, 23 | 17.62 M Decreased by -18.21% | -9.07 M Increased by +37.44% | Decreased by -51.48% Increased by +23.51% |
| Jun 30, 23 | 20.07 M Decreased by -26.37% | -7.41 M Increased by +29.52% | Decreased by -36.91% Increased by +4.27% |